Phase I Dose Esclation of Activated T Cells (ATC) Armed with Anti-CD3 × Anti-CD20 Bispecific Antibody (CD20Bi) after Stem Cell Transplant (SCT) In Non-Hodgkin's Lymphoma (NHL)

Autor: Lum, Lawrence G., Ratanatharathorn, Voravit, Thakur, Archana, Al-Kadhimi, Zaid, Skuba, Cassara, Paul, Elyse N., Steele, Patricia A., Ayash, Lois, Abidi, Muneer H., Uberti, Joseph P.
Zdroj: Blood; November 2010, Vol. 116 Issue: 21 p488-488, 1p
Abstrakt: Lum: Transtarget Inc: Equity Ownership.
Databáze: Supplemental Index